US Biomax, Inc.

MC801

Multiple cancer tissue array, replacing BC00012, 80 cases/80 cores, with grade information

Microarray Panel:Multiple cancer tissue microarray, 10 common types of cancer (breast, cerebrum, colon, esophagus, kidney, liver, lung, prostate, stomach and uterus), 8 cases of each, single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Cer Bre Col Eso Kid Liv Lun Sto Pro Ute  
B Cer Bre Col Eso Kid Liv Lun Sto Pro Ute  
C Cer Bre Col Eso Kid Liv Lun Sto Pro Ute  
D Cer Bre Col Eso Kid Liv Lun Sto Pro Ute  
E Cer Bre Col Eso Kid Liv Lun Sto Pro Ute  
F Cer Bre Col Eso Kid Liv Lun Sto Pro Ute  
G Cer Bre Col Eso Kid Liv Lun Sto Pro Ute  
H Cer Bre Col Eso Kid Liv Lun Sto Pro Ute Marked point
Legend: Bre - Breast, Cer - Cerebrum, Col - Colon, Eso - Esophagus, Kid - Kidney, Liv - Liver, Lun - Lung, Pro - Prostate, Sto - Stomach, Ute - Uterus

- Malignant tumor

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Notes Image Type †
A1 1 F 29 Cerebrum Meningothelial meningeoma Malignant
A2 2 F 59 Breast Infiltrating ductal carcinoma (sparse) 1 Malignant
A3 3 M 58 Colon Adenocarcinoma 1 Malignant
A4 4 M 52 Esophagus Squamous cell carcinoma 1 Malignant
A5 5 M 53 Kidney Clear cell carcinoma 1 – 2 Malignant
A6 6 F 32 Liver Hepatocellular carcinoma 2 Malignant
A7 7 M 60 Lung Adenocarcinoma 2 Malignant
A8 8 M 64 Stomach Adenocarcinoma 1 Malignant
A9 9 M 63 Prostate Adenocarcinoma (hyperplasia) Malignant
A10 10 F 57 Uterus Adenocarcinoma endometrium 1 – 2 Malignant
B1 11 F 47 Cerebrum Meningothelial meningeoma Malignant
B2 12 F 48 Breast Infiltrating ductal carcinoma 1 Malignant
B3 13 F 31 Colon Adenocarcinoma 1 Malignant
B4 14 F 57 Esophagus Squamous cell carcinoma (fibrous tissue, blood vessel and gland tissue) Malignant
B5 15 M 48 Kidney Clear cell carcinoma 1 Malignant
B6 16 M 55 Liver Hepatocellular carcinoma 1 Malignant
B7 17 M 62 Lung Adencarcinoma (sparse) 3 Malignant
B8 18 M 73 Stomach Adenocarcinoma 1 Malignant
B9 19 M 75 Prostate Adenocarcinoma 1 1+1 1 Malignant
B10 20 F 50 Uterus Adenocarcinoma endometrium 1 – 2 Malignant
C1 21 F 52 Cerebrum Meningothelial meningeoma Malignant
C2 22 F 40 Breast Infiltrating ductal carcinoma 2 Malignant
C3 23 M 64 Colon Adenocarcinoma (degenerative and necrotic tissue) Malignant
C4 24 M 62 Esophagus Squamous cell carcinoma 2 Malignant
C5 25 F 50 Kidney Clear cell carcinoma 1 Malignant
C6 26 F 55 Liver Hepatocellular carcinoma 2 Malignant
C7 27 M 47 Lung Adenocarcinoma 3 Malignant
C8 28 F 47 Stomach Adenocarcinoma 2 Malignant
C9 29 M 58 Prostate Adenocarcinoma 2 3+3 3 Malignant
C10 30 F 62 Uterus Adenocarcinoma endometrium 2 Malignant
D1 31 F 45 Cerebrum Meningothelial meningeoma Malignant
D2 32 F 65 Breast Infiltrating ductal carcinoma 2 Malignant
D3 33 M 69 Colon Adenocarcinoma 2 Malignant
D4 34 M 75 Esophagus Squamous cell carcinoma (sparse) Malignant
D5 35 F 56 Kidney Clear cell carcinoma 1 Malignant
D6 36 M 44 Liver Hepatocellular carcinoma 3 Malignant
D7 37 F 51 Lung Adenocarcinoma 3 Malignant
D8 38 M 51 Stomach Mucinous adenocarcinoma 3 Malignant
D9 39 M 76 Prostate Adenocarcinoma (smooth muscle and blood vessel) Malignant
D10 40 F 55 Uterus Adenocarcinoma endometrium 2 Malignant
E1 41 F 53 Cerebrum Fibrous meningioma Malignant
E2 42 F 50 Breast Infiltrating lobular carcinoma Malignant
E3 43 M 43 Colon Mucinous adenocarcinoma 3 Malignant
E4 44 M 75 Esophagus Papillary adenocarcinoma 1 Malignant
E5 45 M 53 Kidney Clear cell carcinoma 2 Malignant
E6 46 F 55 Liver Hepatocellular carcinoma 3 Malignant
E7 47 F 63 Lung Adenocarcinoma 3 Malignant
E8 48 M 49 Stomach Signet-ring cell carcinoma Malignant
E9 49 M 63 Prostate Adenocarcinoma 4 4+5 5 Malignant
E10 50 F 24 Uterus Adenocarcinoma endometrium 3 Malignant
F1 51 F 54 Cerebrum Fibrous meningioma Malignant
F2 52 F 40 Breast Infiltrating lobular carcinoma Malignant
F3 53 M 56 Colon Signet-ring cell carcinoma Malignant
F4 54 M 62 Esophagus Adenocarcinoma 3 Malignant
F5 55 M 88 Kidney Clear cell carcinoma 1 Malignant
F6 56 M 45 Liver Hepatocellular carcinoma 3 Malignant
F7 57 M 61 Lung Adenocarcinoma 3 Malignant
F8 58 F 55 Stomach Adenocarcinoma 3 Malignant
F9 59 M 77 Prostate Adenocarcinoma 3 4+5 5 Malignant
F10 60 F 32 Uterus Rhabdomyosarcoma Malignant
G1 61 F 32 Cerebrum Fibrous meningioma Malignant
G2 62 F 37 Breast Infiltrating lobular carcinoma Malignant
G3 63 M 37 Colon Adenocarcinoma 3 Malignant
G4 64 M 65 Esophagus Adenocarcinoma 3 Malignant
G5 65 M 66 Kidney Clear cell carcinoma 2 – 3 Malignant
G6 66 M 63 Liver Hepatocellular carcinoma 3 Malignant
G7 67 M 57 Lung Squamous cell carcinoma 3 Malignant
G8 68 M 63 Stomach Adenocarcinoma (fibrous tissue and blood vessel) Malignant
G9 69 M 62 Prostate Adenocarcinoma 4 5+5 5 Malignant
G10 70 F 67 Uterus Rhabdomyosarcoma Malignant
H1 71 F 66 Cerebrum Fibrous meningioma Malignant
H2 72 F 40 Breast Infiltrating lobular carcinoma Malignant
H3 73 M 56 Colon Adenocarcinoma 3 Malignant
H4 74 M 64 Esophagus Mucinous adenocarcinoma 2 Malignant
H5 75 M 75 Kidney Clear cell carcinoma 1 – 2 Malignant
H6 76 M 50 Liver Clear cell hepatocellular carcinoma 2 Malignant
H7 77 M 67 Lung Squamous cell carcinoma 2 Malignant
H8 78 M 74 Stomach Adenocarcinoma 3 Malignant
H9 79 M 72 Prostate Adenocarcinoma 4 5+5 5 Malignant
H10 80 F 49 Uterus Rhabdomyosarcoma Malignant
M 58 Skin Malignant melanoma (tissue marker) Malignant


"-" No grading available, *Tissue dots may be missing or histologically unidentifiable. † For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: